BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3318280)

  • 1. [Treatment with intravesical chemotherapy of deep bladder tumors responding to radiotherapy, decreasing their staging].
    Rodríguez Alvarez J; Rodríguez Molina J; Rodríguez Betancour F; Resel Estévez L
    Actas Urol Esp; 1987; 11(4):389-94. PubMed ID: 3318280
    [No Abstract]   [Full Text] [Related]  

  • 2. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
    Colombo R
    Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of intravesical chemotherapy and possibilities for improving its efficacy.
    Sylvester RJ
    Eur Urol; 2006 Aug; 50(2):233. PubMed ID: 18219714
    [No Abstract]   [Full Text] [Related]  

  • 5. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 6. Does radiotherapy still have a place in the treatment of bladder tumors?
    Eschwege F; Raoul Y; Wibault P; Droz JP; Court B; Perrin JL
    Prog Clin Biol Res; 1989; 303():605-11. PubMed ID: 2675015
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
    Sylvester RJ
    Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemoprevention in superficial bladder cancer 1988].
    Rübben H
    Urologe A; 1988 May; 27(3):152-7. PubMed ID: 3043877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Simultaneous chemotherapy/radiotherapy in locally advanced unresectable cancer of the bladder].
    Paule B; Saint F
    Prog Urol; 2001 Feb; 11(1):132-40. PubMed ID: 11296634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial bladder cancer--treatment approach.
    Abi-Aad A; Biquet P; Penders L
    Acta Urol Belg; 1996 May; 64(2):19-24. PubMed ID: 8701801
    [No Abstract]   [Full Text] [Related]  

  • 11. Nursing care of the patient receiving intravesical chemotherapy.
    Switters DM; Soares SE; White RW
    Urol Nurs; 1992 Dec; 12(4):136-9. PubMed ID: 1465638
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessment of mucosal injury in stage T1-T2NOMO bladder cancer after radiation or intravesical chemotherapy].
    Kaprin AD; Panyshin GA; Garmash SV; Kostin AA; Khmelevskiĭ EV; Elagin VO
    Vopr Onkol; 2008; 54(1):98-101. PubMed ID: 18416068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravesical therapy: Influence on superficial bladder cancer progression].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; Alvarez Múgica M; Rodríguez Robles L; Martín Benito JL; San Martín Blanco A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):31-5. PubMed ID: 17408169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytological surveillance of carcinoma in situ during and after intravesical chemotherapy.
    Roth S; Rathert P
    Prog Clin Biol Res; 1989; 303():523-4. PubMed ID: 2780660
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endovesical chemotherapy for superficial bladder tumors].
    Chopin D; Gattegno B
    Prog Urol; 2001 Nov; 11(5):1047-64. PubMed ID: 11769074
    [No Abstract]   [Full Text] [Related]  

  • 16. Vesicorenal reflux and intravesical chemotherapy.
    Mazeman E; Gilliot P
    Prog Clin Biol Res; 1989; 303():517-22. PubMed ID: 2675008
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
    Evans CP
    Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of perioperative intravesical treatment and treatment strategies for these side effects.
    Griffin JG; Holzbeierlein J
    Urol Clin North Am; 2013 May; 40(2):197-210. PubMed ID: 23540778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
    Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
    J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.